Management will provide an update on recent clinical and regulatory developments regarding COVID-19 and other indications for leronlimab.
Hard to say. I sure appreciate the transparency. I would venture to predict there will be something about UK or Philippines moving ahead depending on the 75% data and not waiting until the end of trial. Could be a surprise move for HIV too from UK. I agree about no approval yet or we would have a PR and 8k instead. I am looking forward to hearing from Mahboob.